Patent · US Active

Treatment of diseases linked to pathological kinin formation

US8715672B2 · kind B2 · utility

3Cited by

6References

6Claims

0Family size

Assignee

CSL Behring AG · DE

Inventors

Bernhard Nieswandt · Eibelstadt, DE
Thomas Renné · Bad Sobernheim, DE

Key dates

Filing date	Dec 21, 2012
Grant date	May 6, 2014
Priority date	—
Expiry date	Dec 21, 2032

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the use of at least one antibody and/or one inhibitor for inhibiting factor XII and for preventing the formation and/or the stabilization of three dimensional thrombi. It also relates to a pharmaceutical formulation and the use of factor XII as an anti-thrombotic target.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.